Hypertension Awareness, Treatment, and Control in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study
Overview
Authors
Affiliations
Background: A low rate of blood pressure control has been reported in patients with chronic kidney disease (CKD). These data were derived from population-based samples with a low rate of CKD awareness.
Study Design: Cross-sectional.
Setting & Participants: Data from the baseline visit of the Chronic Renal Insufficiency Cohort (CRIC) Study (n = 3,612) were analyzed. Participants with an estimated glomerular filtration rate of 20-70 mL/min/1.73 m(2) were identified from physician offices and review of laboratory databases.
Outcomes: Prevalence and awareness of hypertension, treatment patterns, control rates, and factors associated with hypertension control.
Measurements: Following a standardized protocol, blood pressure was measured 3 times by trained staff, and hypertension was defined as systolic blood pressure > or =140 mm Hg and/or diastolic blood pressure > or =90 mm Hg and/or self-reported antihypertensive medication use. Patients' awareness and treatment of hypertension were defined using self-report, and 2 levels of hypertension control were evaluated: systolic/diastolic blood pressure <140/90 and <130/80 mm Hg.
Results: The prevalence of hypertension was 85.7%, and 98.9% of CRIC participants were aware of this diagnosis and 98.3% were treated with medications, whereas 67.1% and 46.1% had hypertension controlled to <140/90 and <130/80 mm Hg, respectively. Of CRIC participants with hypertension, 15%, 25%, 26%, and 32% were using 1, 2, 3, and > or =4 antihypertensive medications, respectively. After multivariable adjustment, older patients, blacks, and those with higher urinary albumin excretion were less likely, whereas participants using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers were more likely to have controlled their hypertension to <140/90 and <130/80 mm Hg.
Limitations: Data were derived from a single study visit.
Conclusions: Despite almost universal hypertension awareness and treatment in this cohort of patients with CKD, rates of hypertension control were suboptimal.
Konlan K, Afaya A, Anaman-Torgbor J, Adedia D, Todzro-Agudze M, Biney A BMC Cardiovasc Disord. 2025; 25(1):164.
PMID: 40055593 PMC: 11889812. DOI: 10.1186/s12872-025-04594-y.
Trends in Blood Pressure Control in US Adult CKD Patients from 1999 to 2018.
Sun A, Zhu L, Xia Y, Zheng Y, Hu B, Li F Int J Med Sci. 2025; 22(3):696-707.
PMID: 39898249 PMC: 11783084. DOI: 10.7150/ijms.103107.
Choi H, Jung I, Kim S Antioxidants (Basel). 2025; 14(1).
PMID: 39857434 PMC: 11761572. DOI: 10.3390/antiox14010100.
Prognostic value of nighttime blood pressure in patients with chronic kidney disease.
Li J, Wei Q, Li S, Song J, Wang C, Zhang J Hypertens Res. 2025; .
PMID: 39837965 DOI: 10.1038/s41440-024-02080-0.
Mungamba M, Chilunga F, van der Linden E, Beune E, Godwill E, Hayfron-Benjamin C BMJ Glob Health. 2025; 10(1).
PMID: 39837584 PMC: 11749268. DOI: 10.1136/bmjgh-2024-016786.